Skip to Content

ImmunoPrecise Antibodies Ltd - Stock Quote IPA

Rating as of

Morningstar's ImmunoPrecise Antibodies Ltd Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

ImmunoPrecise Antibodies Ltd's Company Profile

Business Description

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America.

Contact
3204 - 4464 Markham Street
Victoria, BC, V8Z 7X8, Canada
T +1 250 483-0308
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jan 31, 2022
Fiscal Year End Apr 30, 2022
Stock Type
Employees 73